6.
DAmico G, Garcia-Tsao G, Pagliaro L
. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2005; 44(1):217-31.
DOI: 10.1016/j.jhep.2005.10.013.
View
7.
Tranah T, Ballester M, Carbonell-Asins J, Ampuero J, Alexandrino G, Caracostea A
. Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis. J Hepatol. 2022; 77(6):1554-1563.
DOI: 10.1016/j.jhep.2022.07.014.
View
8.
Qi X, Berzigotti A, Cardenas A, Sarin S
. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018; 3(10):708-719.
DOI: 10.1016/S2468-1253(18)30232-2.
View
9.
Lee D, Keum N, Hu F, Orav E, Rimm E, Willett W
. Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study. BMJ. 2018; 362:k2575.
PMC: 6028901.
DOI: 10.1136/bmj.k2575.
View
10.
Diaz A, Wang W, Orejas J, Elalami R, Dolliver W, Nardelli P
. Suspected Bronchiectasis and Mortality in Adults With a History of Smoking Who Have Normal and Impaired Lung Function : A Cohort Study. Ann Intern Med. 2023; 176(10):1340-1348.
PMC: 10809158.
DOI: 10.7326/M23-1125.
View
11.
Sheedfar F, Di Biase S, Koonen D, Vinciguerra M
. Liver diseases and aging: friends or foes?. Aging Cell. 2013; 12(6):950-4.
DOI: 10.1111/acel.12128.
View
12.
Wakkerman F, Wu J, Putter H, Jurgenliemk-Schulz I, Jobsen J, Lutgens L
. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials. Lancet Oncol. 2024; 25(6):779-789.
DOI: 10.1016/S1470-2045(24)00142-6.
View
13.
Wynne H, James O
. The ageing liver. Age Ageing. 1990; 19(1):1-3.
DOI: 10.1093/ageing/19.1.1.
View
14.
Devarbhavi H, Asrani S, Arab J, Nartey Y, Pose E, Kamath P
. Global burden of liver disease: 2023 update. J Hepatol. 2023; 79(2):516-537.
DOI: 10.1016/j.jhep.2023.03.017.
View
15.
Wong Y, Zhaojin C, Tosetti G, Degasperi E, Sharma S, Agarwal S
. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients. Clin Mol Hepatol. 2022; 29(1):135-145.
PMC: 9845679.
DOI: 10.3350/cmh.2022.0181.
View
16.
Gines P, Krag A, Abraldes J, Sola E, Fabrellas N, Kamath P
. Liver cirrhosis. Lancet. 2021; 398(10308):1359-1376.
DOI: 10.1016/S0140-6736(21)01374-X.
View
17.
Frith J, Jones D, Newton J
. Chronic liver disease in an ageing population. Age Ageing. 2008; 38(1):11-8.
DOI: 10.1093/ageing/afn242.
View
18.
Jothimani D, Rela M, Kamath P
. Management of Portal Hypertension in the Older Patient. Curr Gastroenterol Rep. 2024; 26(9):231-240.
DOI: 10.1007/s11894-024-00930-y.
View
19.
Qu Y, Emoto K, Eguchi T, Aly R, Zheng H, Chaft J
. Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma. J Thorac Oncol. 2018; 14(3):482-493.
PMC: 6382593.
DOI: 10.1016/j.jtho.2018.11.017.
View
20.
Zhao L, Wang T, Guo C, Zhou L, Han P, Wang C
. Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis. Hepatol Int. 2022; 16(4):936-943.
PMC: 9349062.
DOI: 10.1007/s12072-022-10359-y.
View